PLAU and COVID-19: Thus, an increase in angiotensin II may contribute to the local microthrombus formation in alveolar capillaries that occurs in patients with COVID-19, as fibrin is not degraded by tissue plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) [262,263].